What is the recommended dosage and treatment regimen for Clarithromycin (Biaxin) in adults?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Clarithromycin Dosage and Treatment Regimen for Adults

For adults, the standard clarithromycin dosage is 1 gram per day in two divided doses (500 mg twice daily) for 7-14 days, with the duration depending on the specific infection being treated. 1

Standard Dosing Guidelines

The FDA-approved dosing regimen for clarithromycin extended-release tablets in adults is:

  • Acute bacterial exacerbation of chronic bronchitis: 1 gram once daily for 7 days 1
  • Acute maxillary sinusitis: 1 gram once daily for 14 days 1
  • Community-acquired pneumonia: 1 gram once daily for 7 days 1

For immediate-release formulations, the dosing is typically:

  • 250-500 mg twice daily (total 500-1000 mg daily) for 7-14 days depending on the infection 2

Specific Infection Protocols

For Pertussis (Whooping Cough)

  • 1 gram per day in two divided doses (500 mg twice daily) for 7 days 2

For H. pylori Eradication

  • Part of standard triple therapy: 500 mg twice daily (with PPI + amoxicillin) for 14 days 3
  • The 14-day regimen is superior to 7-day regimens, with cure rates of approximately 95% versus 86% in susceptible populations 2

For Nontuberculous Mycobacterial Infections

  • For serious skin, soft tissue, and bone infections caused by M. abscessus: 1000 mg/day or azithromycin 250 mg/day combined with parenteral medications (amikacin, cefoxitin, or imipenem) 2
  • For pulmonary disease: typically part of a multi-drug regimen for at least 4-6 months 2

Dosage Adjustments

Renal Impairment

  • Severe renal impairment (CrCl <30 mL/min): Reduce dosage by 50% 1
  • Moderate renal impairment (CrCl 30-60 mL/min) with concomitant atazanavir or ritonavir: Reduce dosage by 50% 1
  • Severe renal impairment with concomitant atazanavir or ritonavir: Reduce dosage by 75% 1

Administration Guidelines

  • Clarithromycin extended-release tablets should be taken with food 1
  • Tablets should be swallowed whole; do not chew, break, or crush extended-release tablets 1

Important Precautions and Contraindications

Contraindications

  • Hypersensitivity to clarithromycin or any macrolide antibiotic 1
  • Concomitant use with cisapride, pimozide, lomitapide, lovastatin, simvastatin, ergot alkaloids, or lurasidone 1
  • History of cholestatic jaundice/hepatic dysfunction with prior clarithromycin use 1
  • Colchicine in patients with renal or hepatic impairment 1

Drug Interactions

  • Clarithromycin inhibits the cytochrome P450 enzyme system (CYP3A), which can lead to increased concentrations of drugs metabolized by this pathway 2
  • Significant interactions with astemizole, cisapride, pimazole, terfenadine, and many other medications 2
  • Reduce clarithromycin dose by 50% when co-administered with atazanavir 1

Common Adverse Effects

  • Gastrointestinal: epigastric distress, abdominal cramps, nausea, vomiting, diarrhea 2
  • Less common: hypersensitivity reactions, hepatotoxicity 2

Antimicrobial Stewardship Considerations

  • Clarithromycin resistance should be considered when selecting therapy, particularly for H. pylori infections 2
  • When resistance to clarithromycin exceeds 15-20%, alternative regimens should be considered 2
  • For H. pylori treatment, culture-guided therapy can increase eradication rates from 72% to 94% compared to empiric therapy 4

Special Populations

  • Pregnancy: FDA Pregnancy Category C - use only when benefits outweigh risks 2
  • Infants <1 month: Not recommended due to potential risk similar to erythromycin-associated infantile hypertrophic pyloric stenosis 2
  • Elderly: No dosage adjustment needed for normal renal function, but increased risk of torsades de pointes 1

By following these evidence-based dosing guidelines and considering patient-specific factors, clarithromycin can be effectively and safely used to treat various bacterial infections in adults.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Peptic Ulcer Disease

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.